HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The number of follicles and ovarian volume in the assessment of response to clomiphene citrate treatment in polycystic ovarian syndrome.

AbstractOBJECTIVE:
To evaluate whether the number of follicles and ovarian volume have any significance in evaluating the response to clomiphene citrate treatment in polycystic ovarian syndrome (PCOS).
DESIGN:
A prospective study of 70 infertile women, 44 of which were diagnosed with polycystic ovarian syndrome.
MAIN OUTCOME MEASURES:
Follicle numbers and volumes in both ovaries, hormonal profile, response to Clomiphene Citrate(CC).
RESULTS:
Ovarian volume was significantly greater in cases with polycystic ovarian syndrome than controls. However, ovarian volume in the Clomiphene Citrate nonresponders was significantly greater than in Clomiphene Citrate responders in the polycystic ovarian syndrome group. The number of small follicles was significantly higher in cases with polycystic ovarian syndrome than controls, and in the Clomiphene Citrate nonresponder group this number was also significantly higher than in Clomiphene Citrate responders. Endocrine features of patients with polycystic ovarian syndrome revealed that Dehydroepiandrostenedione sulfate, Androstenedione, follicle stimulating and luteinizing hormone do not discriminate between patients who respond to Clomiphene Citrate and those who do not respond. However, Testosterone and luteinizing hormone levels differ significantly in responders and nonresponders.
CONCLUSIONS:
Small multiple follicles (> 9) and enlarged ovarian volume (> 6.8 ml) were the most prominent transvaginal ultrasonographic features of ovaries in Clomiphene Citrate nonresponsive patients with polycystic ovarian syndrome. Higher levels of Testosterone, luteinizing hormone and significantly higher number of small follicles were associated with lack of Clomiphene Citrate response. These ultrasonographic features and laboratory assays could be clinically useful for distinguishing better the Clomiphene Citrate nonresponders from responders.
AuthorsC Fiçicioğlu, M Api, S Ozden
JournalActa obstetricia et gynecologica Scandinavica (Acta Obstet Gynecol Scand) Vol. 75 Issue 10 Pg. 917-21 (Nov 1996) ISSN: 0001-6349 [Print] United States
PMID9003093 (Publication Type: Journal Article)
Chemical References
  • Fertility Agents, Female
  • Clomiphene
  • Testosterone
  • Androstenedione
  • Dehydroepiandrosterone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
Topics
  • Adult
  • Androstenedione (blood)
  • Clomiphene (pharmacology, therapeutic use)
  • Dehydroepiandrosterone (blood)
  • Female
  • Fertility Agents, Female (pharmacology, therapeutic use)
  • Follicle Stimulating Hormone (blood)
  • Humans
  • Luteinizing Hormone (blood)
  • Ovarian Follicle (drug effects, physiology)
  • Ovary (anatomy & histology, drug effects)
  • Polycystic Ovary Syndrome (drug therapy)
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: